Heron Therapeutics Announces Approval of ZYNRELEF(R) by Health Canada for the Management of Postoperative Pain

ZYNRELEF is the first and only extended-release local anesthetic approved by Health Canada SAN DIEGO, March 17, 2022 -- (Healthcare Sales & Marketing Network) -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused ... Biopharmaceuticals, Drug Delivery, Regulatory Heron Therapeutics, ZYNRELEF, bupivacaine, meloxicam
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news